Ai Lan

Researchers are suggesting that drugs widely used for the prevention of bone loss could have powerful anticancer properties thoai hoa khop va cach dieu tri with women using bisphosphonates half as likely to develop endometrial cancer as women who do not use the medicine.
Highlighted definition of osteoporosis.
A medicine commonly used to treat bone conditions such as osteoporosis may have potent anticancer properties.

Bisphosphonates - medications that slow or stop the natural dissolving of bone tissue - have previously been identified as having the ability to prevent tumor cells from multiplying or invading other healthy tissues.

These drugs are commonly used to treat osteoporosis, a condition whereby bones become weak and brittle as not enough new bone tissue is created to sufficiently replace old, broken down tissue.

According to the researchers, thuoc chua thoai hoa khop endometrial cancer accounts for almost half of all new gynecological cancers diagnosed in the US. It is also the fourth most common malignancy to be diagnosed in women. In 2014, an estimated 52,630 cases of uterine cancer will have been diagnosed, with around 8,590 women dying from endometrial cancer (98%) and uterine sarcomas (2%).

Bisphosphonates have already been shown by researchers to reduce the risk of other cancers, but according to lead author Dr. Sharon H. Alford, this study is the first to show the risk of endometrial cancer may also be reduced.

For the study, published in CANCER, the team analyzed data from the National Cancer Institute's Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial. This data included questionnaires containing information on bone medication use.

In their analysis, the researchers chose only to investigate bisphosphonates containing nitrogen, as these have been identified as having stronger anticancer activity.
Nitrogen form of bisphosphonates 'may reduce the endometrial cancer risk'

Data for 29,254 women were examined by the team. They took into account factors known to be associated with high or low estrogen exposure such as age, thoai hoa khop body mass index (BMI) and